nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A3—germ cell cancer	0.603	1	CbGaD
Clonidine—SLC22A5—Dactinomycin—germ cell cancer	0.0767	0.317	CbGbCtD
Clonidine—CYP3A5—Ifosfamide—germ cell cancer	0.0353	0.146	CbGbCtD
Clonidine—ABCB1—Dactinomycin—germ cell cancer	0.0195	0.0805	CbGbCtD
Clonidine—CYP3A5—Etoposide—germ cell cancer	0.0169	0.0698	CbGbCtD
Clonidine—CYP3A4—Ifosfamide—germ cell cancer	0.0138	0.057	CbGbCtD
Clonidine—CYP1A2—Etoposide—germ cell cancer	0.0126	0.052	CbGbCtD
Clonidine—ABCB1—Vinblastine—germ cell cancer	0.0122	0.0505	CbGbCtD
Clonidine—CYP2D6—Vinblastine—germ cell cancer	0.0115	0.0475	CbGbCtD
Clonidine—ABCB1—Cisplatin—germ cell cancer	0.0112	0.0463	CbGbCtD
Clonidine—ABCB1—Etoposide—germ cell cancer	0.011	0.0455	CbGbCtD
Clonidine—CYP3A4—Vinblastine—germ cell cancer	0.00731	0.0302	CbGbCtD
Clonidine—ABCB1—Methotrexate—germ cell cancer	0.00726	0.03	CbGbCtD
Clonidine—CYP3A4—Etoposide—germ cell cancer	0.00658	0.0272	CbGbCtD
Clonidine—SLC22A4—Organic cation transport—SLC22A3—germ cell cancer	0.00358	0.111	CbGpPWpGaD
Clonidine—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.00269	0.0834	CbGpPWpGaD
Clonidine—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00243	0.0752	CbGpPWpGaD
Clonidine—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.0023	0.0712	CbGpPWpGaD
Clonidine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00182	0.0565	CbGpPWpGaD
Clonidine—NISCH—Podofilox—Etoposide—germ cell cancer	0.00175	0.539	CbGdCrCtD
Clonidine—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00158	0.0489	CbGpPWpGaD
Clonidine—NISCH—Vincristine—Vinblastine—germ cell cancer	0.00149	0.461	CbGdCrCtD
Clonidine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00135	0.0417	CbGpPWpGaD
Clonidine—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00132	0.0409	CbGpPWpGaD
Clonidine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00107	0.0332	CbGpPWpGaD
Clonidine—SLC22A1—ganglion—germ cell cancer	0.00106	0.0271	CbGeAlD
Clonidine—CYP1A2—urine—germ cell cancer	0.000975	0.025	CbGeAlD
Clonidine—SLC6A2—ganglion—germ cell cancer	0.000864	0.0222	CbGeAlD
Clonidine—CYP1A1—skin epidermis—germ cell cancer	0.000779	0.02	CbGeAlD
Clonidine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000774	0.024	CbGpPWpGaD
Clonidine—CYP3A4—urine—germ cell cancer	0.000706	0.0181	CbGeAlD
Clonidine—CYP2D6—urine—germ cell cancer	0.000695	0.0178	CbGeAlD
Clonidine—NISCH—telencephalon—germ cell cancer	0.000647	0.0166	CbGeAlD
Clonidine—SLC6A2—Monoamine Transport—PVRL2—germ cell cancer	0.00064	0.0198	CbGpPWpGaD
Clonidine—SLC22A4—neck—germ cell cancer	0.000631	0.0162	CbGeAlD
Clonidine—NISCH—decidua—germ cell cancer	0.000613	0.0157	CbGeAlD
Clonidine—ADRA1D—telencephalon—germ cell cancer	0.00054	0.0139	CbGeAlD
Clonidine—NISCH—uterus—germ cell cancer	0.000536	0.0138	CbGeAlD
Clonidine—NISCH—pituitary gland—germ cell cancer	0.000527	0.0135	CbGeAlD
Clonidine—NISCH—medulla oblongata—germ cell cancer	0.000508	0.013	CbGeAlD
Clonidine—SLC22A3—trigeminal ganglion—germ cell cancer	0.000496	0.0127	CbGeAlD
Clonidine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000494	0.0153	CbGpPWpGaD
Clonidine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000486	0.0151	CbGpPWpGaD
Clonidine—SLC22A3—embryo—germ cell cancer	0.000479	0.0123	CbGeAlD
Clonidine—NISCH—adrenal gland—germ cell cancer	0.00047	0.0121	CbGeAlD
Clonidine—NISCH—midbrain—germ cell cancer	0.000464	0.0119	CbGeAlD
Clonidine—NISCH—bone marrow—germ cell cancer	0.000455	0.0117	CbGeAlD
Clonidine—NISCH—spinal cord—germ cell cancer	0.000453	0.0116	CbGeAlD
Clonidine—NISCH—female gonad—germ cell cancer	0.000439	0.0113	CbGeAlD
Clonidine—SLC22A1—telencephalon—germ cell cancer	0.000407	0.0105	CbGeAlD
Clonidine—SLC22A4—decidua—germ cell cancer	0.000405	0.0104	CbGeAlD
Clonidine—NISCH—testis—germ cell cancer	0.000389	0.00999	CbGeAlD
Clonidine—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000388	0.012	CbGpPWpGaD
Clonidine—ADRA2C—trigeminal ganglion—germ cell cancer	0.000376	0.00966	CbGeAlD
Clonidine—SLC6A2—brainstem—germ cell cancer	0.000376	0.00965	CbGeAlD
Clonidine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000372	0.0115	CbGpPWpGaD
Clonidine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000371	0.0115	CbGpPWpGaD
Clonidine—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000367	0.0114	CbGpPWpGaD
Clonidine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000366	0.0113	CbGpPWpGaD
Clonidine—SLC22A5—trigeminal ganglion—germ cell cancer	0.00036	0.00925	CbGeAlD
Clonidine—NISCH—cerebellum—germ cell cancer	0.000359	0.00922	CbGeAlD
Clonidine—ADRA1A—brainstem—germ cell cancer	0.000349	0.00897	CbGeAlD
Clonidine—SLC22A4—pituitary gland—germ cell cancer	0.000348	0.00894	CbGeAlD
Clonidine—ADRA1B—head—germ cell cancer	0.000344	0.00882	CbGeAlD
Clonidine—ADRA1D—endocrine gland—germ cell cancer	0.00034	0.00874	CbGeAlD
Clonidine—ADRA1D—head—germ cell cancer	0.000336	0.00863	CbGeAlD
Clonidine—SLC6A2—telencephalon—germ cell cancer	0.000333	0.00856	CbGeAlD
Clonidine—SLC22A3—gonad—germ cell cancer	0.000325	0.00834	CbGeAlD
Clonidine—SLC6A2—decidua—germ cell cancer	0.000316	0.00811	CbGeAlD
Clonidine—SLC22A4—adrenal gland—germ cell cancer	0.000311	0.00798	CbGeAlD
Clonidine—ADRA1A—telencephalon—germ cell cancer	0.00031	0.00796	CbGeAlD
Clonidine—SLC22A5—retina—germ cell cancer	0.000308	0.0079	CbGeAlD
Clonidine—SLC22A4—bone marrow—germ cell cancer	0.000301	0.00772	CbGeAlD
Clonidine—ADRA2A—trigeminal ganglion—germ cell cancer	0.0003	0.00771	CbGeAlD
Clonidine—SLC22A4—spinal cord—germ cell cancer	0.0003	0.00769	CbGeAlD
Clonidine—ADRA2C—telencephalon—germ cell cancer	0.000295	0.00758	CbGeAlD
Clonidine—NISCH—brain—germ cell cancer	0.000292	0.00749	CbGeAlD
Clonidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00029	0.00898	CbGpPWpGaD
Clonidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000285	0.00884	CbGpPWpGaD
Clonidine—SLC22A3—adrenal gland—germ cell cancer	0.000283	0.00727	CbGeAlD
Clonidine—NISCH—lymph node—germ cell cancer	0.000282	0.00724	CbGeAlD
Clonidine—ADRA2C—decidua—germ cell cancer	0.00028	0.00719	CbGeAlD
Clonidine—SLC6A2—gonad—germ cell cancer	0.000278	0.00714	CbGeAlD
Clonidine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000276	0.00855	CbGpPWpGaD
Clonidine—ABCB1—blood vessel—germ cell cancer	0.000271	0.00695	CbGeAlD
Clonidine—SLC22A5—skin of body—germ cell cancer	0.00027	0.00693	CbGeAlD
Clonidine—SLC22A3—female gonad—germ cell cancer	0.000264	0.00678	CbGeAlD
Clonidine—SLC6A2—medulla oblongata—germ cell cancer	0.000262	0.00673	CbGeAlD
Clonidine—SLC22A1—endocrine gland—germ cell cancer	0.000257	0.00659	CbGeAlD
Clonidine—SLC22A1—head—germ cell cancer	0.000254	0.00651	CbGeAlD
Clonidine—ADRA1B—brain—germ cell cancer	0.000249	0.00639	CbGeAlD
Clonidine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000249	0.00306	CcSEcCtD
Clonidine—Bradycardia—Cisplatin—germ cell cancer	0.000248	0.00305	CcSEcCtD
Clonidine—Mental disorder—Ifosfamide—germ cell cancer	0.000247	0.00304	CcSEcCtD
Clonidine—Erythema—Ifosfamide—germ cell cancer	0.000246	0.00302	CcSEcCtD
Clonidine—SLC22A3—endocrine gland—germ cell cancer	0.000245	0.0063	CbGeAlD
Clonidine—ADRA2C—uterus—germ cell cancer	0.000245	0.00629	CbGeAlD
Clonidine—Chest pain—Bleomycin—germ cell cancer	0.000245	0.00301	CcSEcCtD
Clonidine—ADRA1D—brain—germ cell cancer	0.000244	0.00625	CbGeAlD
Clonidine—SLC6A2—adrenal gland—germ cell cancer	0.000243	0.00623	CbGeAlD
Clonidine—SLC22A3—head—germ cell cancer	0.000242	0.00622	CbGeAlD
Clonidine—Discomfort—Bleomycin—germ cell cancer	0.000242	0.00298	CcSEcCtD
Clonidine—Malaise—Dactinomycin—germ cell cancer	0.000242	0.00298	CcSEcCtD
Clonidine—Decreased appetite—Vinblastine—germ cell cancer	0.000241	0.00297	CcSEcCtD
Clonidine—CYP1A1—skin of body—germ cell cancer	0.000241	0.0062	CbGeAlD
Clonidine—ADRA2C—pituitary gland—germ cell cancer	0.000241	0.00617	CbGeAlD
Clonidine—Gynaecomastia—Methotrexate—germ cell cancer	0.000238	0.00293	CcSEcCtD
Clonidine—SLC22A4—cerebellum—germ cell cancer	0.000238	0.0061	CbGeAlD
Clonidine—Constipation—Vinblastine—germ cell cancer	0.000237	0.00292	CcSEcCtD
Clonidine—Pain—Vinblastine—germ cell cancer	0.000237	0.00292	CcSEcCtD
Clonidine—Confusional state—Bleomycin—germ cell cancer	0.000236	0.00291	CcSEcCtD
Clonidine—ADRA2A—telencephalon—germ cell cancer	0.000236	0.00605	CbGeAlD
Clonidine—Oedema—Bleomycin—germ cell cancer	0.000235	0.00289	CcSEcCtD
Clonidine—SLC22A3—testis—germ cell cancer	0.000234	0.00601	CbGeAlD
Clonidine—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000234	0.00724	CbGpPWpGaD
Clonidine—Infection—Bleomycin—germ cell cancer	0.000233	0.00287	CcSEcCtD
Clonidine—ADRA2C—medulla oblongata—germ cell cancer	0.000232	0.00596	CbGeAlD
Clonidine—Vision blurred—Ifosfamide—germ cell cancer	0.000231	0.00285	CcSEcCtD
Clonidine—SLC22A5—pituitary gland—germ cell cancer	0.00023	0.00591	CbGeAlD
Clonidine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00023	0.00283	CcSEcCtD
Clonidine—Feeling abnormal—Vinblastine—germ cell cancer	0.000229	0.00282	CcSEcCtD
Clonidine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000228	0.00281	CcSEcCtD
Clonidine—Eye disorder—Cisplatin—germ cell cancer	0.000227	0.0028	CcSEcCtD
Clonidine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000227	0.0028	CcSEcCtD
Clonidine—Tinnitus—Cisplatin—germ cell cancer	0.000227	0.00279	CcSEcCtD
Clonidine—Cardiac disorder—Cisplatin—germ cell cancer	0.000226	0.00278	CcSEcCtD
Clonidine—Agitation—Ifosfamide—germ cell cancer	0.000226	0.00278	CcSEcCtD
Clonidine—ADRA1A—adrenal gland—germ cell cancer	0.000226	0.00579	CbGeAlD
Clonidine—Discomfort—Dactinomycin—germ cell cancer	0.000225	0.00278	CcSEcCtD
Clonidine—Angioedema—Ifosfamide—germ cell cancer	0.000224	0.00276	CcSEcCtD
Clonidine—SLC22A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000224	0.00695	CbGpPWpGaD
Clonidine—Anorexia—Bleomycin—germ cell cancer	0.000224	0.00275	CcSEcCtD
Clonidine—ADRA2A—decidua—germ cell cancer	0.000223	0.00574	CbGeAlD
Clonidine—SLC22A5—medulla oblongata—germ cell cancer	0.000222	0.00571	CbGeAlD
Clonidine—Hypoaesthesia—Etoposide—germ cell cancer	0.000222	0.00273	CcSEcCtD
Clonidine—Malaise—Ifosfamide—germ cell cancer	0.000221	0.00273	CcSEcCtD
Clonidine—SLC22A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000221	0.00685	CbGpPWpGaD
Clonidine—Abdominal pain—Vinblastine—germ cell cancer	0.00022	0.0027	CcSEcCtD
Clonidine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000219	0.0027	CcSEcCtD
Clonidine—Hypotension—Bleomycin—germ cell cancer	0.000219	0.0027	CcSEcCtD
Clonidine—Oedema—Dactinomycin—germ cell cancer	0.000219	0.00269	CcSEcCtD
Clonidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000218	0.00674	CbGpPWpGaD
Clonidine—Infection—Dactinomycin—germ cell cancer	0.000217	0.00268	CcSEcCtD
Clonidine—Arrhythmia—Cisplatin—germ cell cancer	0.000217	0.00268	CcSEcCtD
Clonidine—Palpitations—Ifosfamide—germ cell cancer	0.000217	0.00267	CcSEcCtD
Clonidine—Alopecia—Cisplatin—germ cell cancer	0.000215	0.00265	CcSEcCtD
Clonidine—ADRA2C—adrenal gland—germ cell cancer	0.000215	0.00552	CbGeAlD
Clonidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000214	0.00664	CbGpPWpGaD
Clonidine—Cough—Ifosfamide—germ cell cancer	0.000214	0.00264	CcSEcCtD
Clonidine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000214	0.00264	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000214	0.00263	CcSEcCtD
Clonidine—ADRA2C—midbrain—germ cell cancer	0.000212	0.00545	CbGeAlD
Clonidine—Erythema—Cisplatin—germ cell cancer	0.000212	0.00261	CcSEcCtD
Clonidine—Paraesthesia—Bleomycin—germ cell cancer	0.000211	0.00259	CcSEcCtD
Clonidine—SLC6A2—endocrine gland—germ cell cancer	0.00021	0.0054	CbGeAlD
Clonidine—CYP1A1—uterus—germ cell cancer	0.00021	0.00538	CbGeAlD
Clonidine—Dyspnoea—Bleomycin—germ cell cancer	0.000209	0.00257	CcSEcCtD
Clonidine—Arthralgia—Ifosfamide—germ cell cancer	0.000209	0.00257	CcSEcCtD
Clonidine—Chest pain—Ifosfamide—germ cell cancer	0.000209	0.00257	CcSEcCtD
Clonidine—SLC6A2—NRF2 pathway—SLC2A3—germ cell cancer	0.000209	0.00647	CbGpPWpGaD
Clonidine—Anorexia—Dactinomycin—germ cell cancer	0.000208	0.00257	CcSEcCtD
Clonidine—Eye disorder—Etoposide—germ cell cancer	0.000208	0.00256	CcSEcCtD
Clonidine—SLC6A2—head—germ cell cancer	0.000208	0.00533	CbGeAlD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000208	0.00256	CcSEcCtD
Clonidine—ADRA2C—spinal cord—germ cell cancer	0.000207	0.00531	CbGeAlD
Clonidine—Cardiac disorder—Etoposide—germ cell cancer	0.000207	0.00255	CcSEcCtD
Clonidine—Discomfort—Ifosfamide—germ cell cancer	0.000207	0.00254	CcSEcCtD
Clonidine—SLC22A5—adrenal gland—germ cell cancer	0.000206	0.00528	CbGeAlD
Clonidine—CYP2D6—brainstem—germ cell cancer	0.000206	0.00528	CbGeAlD
Clonidine—Hypersensitivity—Vinblastine—germ cell cancer	0.000205	0.00252	CcSEcCtD
Clonidine—Decreased appetite—Bleomycin—germ cell cancer	0.000204	0.00251	CcSEcCtD
Clonidine—Muscle spasms—Cisplatin—germ cell cancer	0.000204	0.00251	CcSEcCtD
Clonidine—SLC22A5—midbrain—germ cell cancer	0.000203	0.00522	CbGeAlD
Clonidine—Angiopathy—Etoposide—germ cell cancer	0.000202	0.00249	CcSEcCtD
Clonidine—Confusional state—Ifosfamide—germ cell cancer	0.000202	0.00249	CcSEcCtD
Clonidine—Mediastinal disorder—Etoposide—germ cell cancer	0.000201	0.00247	CcSEcCtD
Clonidine—SLC6A2—testis—germ cell cancer	0.000201	0.00515	CbGeAlD
Clonidine—Pain—Bleomycin—germ cell cancer	0.000201	0.00247	CcSEcCtD
Clonidine—Oedema—Ifosfamide—germ cell cancer	0.0002	0.00247	CcSEcCtD
Clonidine—ADRA2C—female gonad—germ cell cancer	0.0002	0.00514	CbGeAlD
Clonidine—Vision blurred—Cisplatin—germ cell cancer	0.0002	0.00246	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000199	0.00245	CcSEcCtD
Clonidine—Asthenia—Vinblastine—germ cell cancer	0.000199	0.00245	CcSEcCtD
Clonidine—Infection—Ifosfamide—germ cell cancer	0.000199	0.00245	CcSEcCtD
Clonidine—Tremor—Cisplatin—germ cell cancer	0.000198	0.00244	CcSEcCtD
Clonidine—SLC22A5—spinal cord—germ cell cancer	0.000198	0.00509	CbGeAlD
Clonidine—Alopecia—Etoposide—germ cell cancer	0.000197	0.00242	CcSEcCtD
Clonidine—Lethargy—Methotrexate—germ cell cancer	0.000197	0.00242	CcSEcCtD
Clonidine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000197	0.00242	CcSEcCtD
Clonidine—ADRA2A—gonad—germ cell cancer	0.000197	0.00505	CbGeAlD
Clonidine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000197	0.00242	CcSEcCtD
Clonidine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000196	0.00242	CcSEcCtD
Clonidine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000196	0.00242	CcSEcCtD
Clonidine—ADRA1A—endocrine gland—germ cell cancer	0.000196	0.00502	CbGeAlD
Clonidine—ADRA2A—uterus—germ cell cancer	0.000195	0.00502	CbGeAlD
Clonidine—Skin disorder—Ifosfamide—germ cell cancer	0.000195	0.0024	CcSEcCtD
Clonidine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000194	0.00239	CcSEcCtD
Clonidine—Feeling abnormal—Bleomycin—germ cell cancer	0.000193	0.00238	CcSEcCtD
Clonidine—ADRA1A—head—germ cell cancer	0.000193	0.00496	CbGeAlD
Clonidine—SLC22A4—brain—germ cell cancer	0.000193	0.00495	CbGeAlD
Clonidine—ADRA2A—pituitary gland—germ cell cancer	0.000192	0.00493	CbGeAlD
Clonidine—SLC22A5—female gonad—germ cell cancer	0.000192	0.00493	CbGeAlD
Clonidine—Anorexia—Ifosfamide—germ cell cancer	0.000191	0.00235	CcSEcCtD
Clonidine—Malaise—Cisplatin—germ cell cancer	0.000191	0.00235	CcSEcCtD
Clonidine—Decreased appetite—Dactinomycin—germ cell cancer	0.00019	0.00234	CcSEcCtD
Clonidine—Diarrhoea—Vinblastine—germ cell cancer	0.00019	0.00234	CcSEcCtD
Clonidine—Fatigue—Dactinomycin—germ cell cancer	0.000189	0.00232	CcSEcCtD
Clonidine—Hypotension—Ifosfamide—germ cell cancer	0.000187	0.00231	CcSEcCtD
Clonidine—Pain—Dactinomycin—germ cell cancer	0.000187	0.0023	CcSEcCtD
Clonidine—Muscle spasms—Etoposide—germ cell cancer	0.000186	0.0023	CcSEcCtD
Clonidine—SLC22A4—lymph node—germ cell cancer	0.000186	0.00479	CbGeAlD
Clonidine—Urticaria—Bleomycin—germ cell cancer	0.000186	0.00229	CcSEcCtD
Clonidine—Body temperature increased—Bleomycin—germ cell cancer	0.000185	0.00228	CcSEcCtD
Clonidine—ADRA2A—medulla oblongata—germ cell cancer	0.000185	0.00475	CbGeAlD
Clonidine—Irritability—Methotrexate—germ cell cancer	0.000184	0.00227	CcSEcCtD
Clonidine—ADRA2C—head—germ cell cancer	0.000184	0.00472	CbGeAlD
Clonidine—SLC22A1—brain—germ cell cancer	0.000184	0.00472	CbGeAlD
Clonidine—Dizziness—Vinblastine—germ cell cancer	0.000184	0.00226	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000183	0.00225	CcSEcCtD
Clonidine—CYP2D6—telencephalon—germ cell cancer	0.000183	0.00469	CbGeAlD
Clonidine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00018	0.00559	CbGpPWpGaD
Clonidine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00018	0.00222	CcSEcCtD
Clonidine—Paraesthesia—Ifosfamide—germ cell cancer	0.00018	0.00222	CcSEcCtD
Clonidine—Ill-defined disorder—Etoposide—germ cell cancer	0.00018	0.00222	CcSEcCtD
Clonidine—Anxiety—Cisplatin—germ cell cancer	0.00018	0.00221	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000179	0.0022	CcSEcCtD
Clonidine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000179	0.0022	CcSEcCtD
Clonidine—Dyspnoea—Ifosfamide—germ cell cancer	0.000179	0.0022	CcSEcCtD
Clonidine—Somnolence—Ifosfamide—germ cell cancer	0.000178	0.00219	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000178	0.00219	CcSEcCtD
Clonidine—Discomfort—Cisplatin—germ cell cancer	0.000178	0.00219	CcSEcCtD
Clonidine—ADRA2C—testis—germ cell cancer	0.000178	0.00456	CbGeAlD
Clonidine—Vomiting—Vinblastine—germ cell cancer	0.000177	0.00217	CcSEcCtD
Clonidine—SLC22A3—brain—germ cell cancer	0.000176	0.00451	CbGeAlD
Clonidine—Malaise—Etoposide—germ cell cancer	0.000175	0.00215	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—germ cell cancer	0.000174	0.00215	CcSEcCtD
Clonidine—SLC22A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000174	0.0054	CbGpPWpGaD
Clonidine—Decreased appetite—Ifosfamide—germ cell cancer	0.000174	0.00215	CcSEcCtD
Clonidine—Headache—Vinblastine—germ cell cancer	0.000174	0.00214	CcSEcCtD
Clonidine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—Body temperature increased—Dactinomycin—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—Abdominal pain—Dactinomycin—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—Fatigue—Ifosfamide—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—Oedema—Cisplatin—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—Hypersensitivity—Bleomycin—germ cell cancer	0.000173	0.00213	CcSEcCtD
Clonidine—ADRA1A—cerebellum—germ cell cancer	0.000172	0.00442	CbGeAlD
Clonidine—Infection—Cisplatin—germ cell cancer	0.000172	0.00211	CcSEcCtD
Clonidine—CYP1A1—female gonad—germ cell cancer	0.000172	0.0044	CbGeAlD
Clonidine—ADRA2A—adrenal gland—germ cell cancer	0.000171	0.0044	CbGeAlD
Clonidine—Pain—Ifosfamide—germ cell cancer	0.000171	0.00211	CcSEcCtD
Clonidine—Constipation—Ifosfamide—germ cell cancer	0.000171	0.00211	CcSEcCtD
Clonidine—Loss of consciousness—Etoposide—germ cell cancer	0.00017	0.0021	CcSEcCtD
Clonidine—SLC22A5—testis—germ cell cancer	0.00017	0.00437	CbGeAlD
Clonidine—SLC22A3—lymph node—germ cell cancer	0.00017	0.00436	CbGeAlD
Clonidine—Nervous system disorder—Cisplatin—germ cell cancer	0.000169	0.00209	CcSEcCtD
Clonidine—ADRA2A—midbrain—germ cell cancer	0.000169	0.00435	CbGeAlD
Clonidine—Cough—Etoposide—germ cell cancer	0.000169	0.00208	CcSEcCtD
Clonidine—SLC22A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000169	0.00524	CbGpPWpGaD
Clonidine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000169	0.00208	CcSEcCtD
Clonidine—Tachycardia—Cisplatin—germ cell cancer	0.000169	0.00208	CcSEcCtD
Clonidine—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000169	0.00522	CbGpPWpGaD
Clonidine—Asthenia—Bleomycin—germ cell cancer	0.000168	0.00207	CcSEcCtD
Clonidine—Skin disorder—Cisplatin—germ cell cancer	0.000168	0.00207	CcSEcCtD
Clonidine—CYP3A5—female gonad—germ cell cancer	0.000168	0.0043	CbGeAlD
Clonidine—ABCB1—trigeminal ganglion—germ cell cancer	0.000167	0.00429	CbGeAlD
Clonidine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000167	0.00206	CcSEcCtD
Clonidine—Asthma—Methotrexate—germ cell cancer	0.000167	0.00205	CcSEcCtD
Clonidine—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000166	0.00515	CbGpPWpGaD
Clonidine—Pruritus—Bleomycin—germ cell cancer	0.000166	0.00204	CcSEcCtD
Clonidine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000165	0.00203	CcSEcCtD
Clonidine—ADRA2A—spinal cord—germ cell cancer	0.000165	0.00424	CbGeAlD
Clonidine—Chest pain—Etoposide—germ cell cancer	0.000165	0.00203	CcSEcCtD
Clonidine—Nausea—Vinblastine—germ cell cancer	0.000165	0.00203	CcSEcCtD
Clonidine—Anorexia—Cisplatin—germ cell cancer	0.000165	0.00203	CcSEcCtD
Clonidine—ADRA2C—cerebellum—germ cell cancer	0.000164	0.00421	CbGeAlD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000164	0.00202	CcSEcCtD
Clonidine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000164	0.00202	CcSEcCtD
Clonidine—Discomfort—Etoposide—germ cell cancer	0.000163	0.00201	CcSEcCtD
Clonidine—CYP1A2—endocrine gland—germ cell cancer	0.000162	0.00415	CbGeAlD
Clonidine—ABCB1—embryo—germ cell cancer	0.000162	0.00415	CbGeAlD
Clonidine—Hypotension—Cisplatin—germ cell cancer	0.000161	0.00199	CcSEcCtD
Clonidine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000161	0.00198	CcSEcCtD
Clonidine—ADRA2A—female gonad—germ cell cancer	0.00016	0.0041	CbGeAlD
Clonidine—Confusional state—Etoposide—germ cell cancer	0.00016	0.00197	CcSEcCtD
Clonidine—CYP1A1—endocrine gland—germ cell cancer	0.00016	0.00409	CbGeAlD
Clonidine—Urticaria—Ifosfamide—germ cell cancer	0.000159	0.00196	CcSEcCtD
Clonidine—Body temperature increased—Ifosfamide—germ cell cancer	0.000158	0.00195	CcSEcCtD
Clonidine—Abdominal pain—Ifosfamide—germ cell cancer	0.000158	0.00195	CcSEcCtD
Clonidine—CYP1A1—head—germ cell cancer	0.000157	0.00404	CbGeAlD
Clonidine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000157	0.00194	CcSEcCtD
Clonidine—Infection—Etoposide—germ cell cancer	0.000157	0.00194	CcSEcCtD
Clonidine—SLC22A5—cerebellum—germ cell cancer	0.000157	0.00404	CbGeAlD
Clonidine—Asthenia—Dactinomycin—germ cell cancer	0.000157	0.00193	CcSEcCtD
Clonidine—CYP3A5—endocrine gland—germ cell cancer	0.000156	0.004	CbGeAlD
Clonidine—Dysuria—Methotrexate—germ cell cancer	0.000156	0.00192	CcSEcCtD
Clonidine—Paraesthesia—Cisplatin—germ cell cancer	0.000155	0.00191	CcSEcCtD
Clonidine—Thrombocytopenia—Etoposide—germ cell cancer	0.000155	0.00191	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000155	0.00191	CcSEcCtD
Clonidine—Tachycardia—Etoposide—germ cell cancer	0.000155	0.0019	CcSEcCtD
Clonidine—Dyspnoea—Cisplatin—germ cell cancer	0.000154	0.0019	CcSEcCtD
Clonidine—Skin disorder—Etoposide—germ cell cancer	0.000154	0.00189	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000154	0.00189	CcSEcCtD
Clonidine—Hyperhidrosis—Etoposide—germ cell cancer	0.000153	0.00188	CcSEcCtD
Clonidine—Anorexia—Etoposide—germ cell cancer	0.000151	0.00186	CcSEcCtD
Clonidine—SLC6A2—brain—germ cell cancer	0.00015	0.00386	CbGeAlD
Clonidine—Decreased appetite—Cisplatin—germ cell cancer	0.00015	0.00185	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—germ cell cancer	0.00015	0.00184	CcSEcCtD
Clonidine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000149	0.00184	CcSEcCtD
Clonidine—Vomiting—Bleomycin—germ cell cancer	0.000149	0.00184	CcSEcCtD
Clonidine—ADRA2A—endocrine gland—germ cell cancer	0.000149	0.00382	CbGeAlD
Clonidine—Drowsiness—Methotrexate—germ cell cancer	0.000149	0.00183	CcSEcCtD
Clonidine—Depression—Methotrexate—germ cell cancer	0.000148	0.00183	CcSEcCtD
Clonidine—Hypotension—Etoposide—germ cell cancer	0.000148	0.00182	CcSEcCtD
Clonidine—Rash—Bleomycin—germ cell cancer	0.000148	0.00182	CcSEcCtD
Clonidine—Pain—Cisplatin—germ cell cancer	0.000148	0.00182	CcSEcCtD
Clonidine—Dermatitis—Bleomycin—germ cell cancer	0.000148	0.00182	CcSEcCtD
Clonidine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000148	0.00182	CcSEcCtD
Clonidine—ADRA2A—head—germ cell cancer	0.000147	0.00377	CbGeAlD
Clonidine—SLC6A2—lymph node—germ cell cancer	0.000145	0.00373	CbGeAlD
Clonidine—Asthenia—Ifosfamide—germ cell cancer	0.000144	0.00177	CcSEcCtD
Clonidine—ABCB1—retina—germ cell cancer	0.000143	0.00367	CbGeAlD
Clonidine—Sweating—Methotrexate—germ cell cancer	0.000143	0.00176	CcSEcCtD
Clonidine—Feeling abnormal—Cisplatin—germ cell cancer	0.000142	0.00175	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—germ cell cancer	0.000142	0.00175	CcSEcCtD
Clonidine—Pruritus—Ifosfamide—germ cell cancer	0.000142	0.00175	CcSEcCtD
Clonidine—ADRA2A—testis—germ cell cancer	0.000142	0.00364	CbGeAlD
Clonidine—Dyspnoea—Etoposide—germ cell cancer	0.000141	0.00174	CcSEcCtD
Clonidine—Somnolence—Etoposide—germ cell cancer	0.000141	0.00173	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—germ cell cancer	0.00014	0.00173	CcSEcCtD
Clonidine—ADRA1A—brain—germ cell cancer	0.00014	0.00359	CbGeAlD
Clonidine—Nausea—Bleomycin—germ cell cancer	0.000139	0.00172	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—germ cell cancer	0.000139	0.00171	CcSEcCtD
Clonidine—Rash—Dactinomycin—germ cell cancer	0.000138	0.0017	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—germ cell cancer	0.000138	0.00169	CcSEcCtD
Clonidine—Diarrhoea—Ifosfamide—germ cell cancer	0.000137	0.00169	CcSEcCtD
Clonidine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000137	0.00168	CcSEcCtD
Clonidine—Body temperature increased—Cisplatin—germ cell cancer	0.000137	0.00168	CcSEcCtD
Clonidine—Fatigue—Etoposide—germ cell cancer	0.000136	0.00168	CcSEcCtD
Clonidine—Pain—Etoposide—germ cell cancer	0.000135	0.00167	CcSEcCtD
Clonidine—Constipation—Etoposide—germ cell cancer	0.000135	0.00167	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—germ cell cancer	0.000133	0.00164	CcSEcCtD
Clonidine—ADRA2C—brain—germ cell cancer	0.000133	0.00342	CbGeAlD
Clonidine—Dizziness—Ifosfamide—germ cell cancer	0.000133	0.00163	CcSEcCtD
Clonidine—SLC6A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000132	0.00408	CbGpPWpGaD
Clonidine—SLC22A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000131	0.00407	CbGpPWpGaD
Clonidine—ABCB1—telencephalon—germ cell cancer	0.000131	0.00337	CbGeAlD
Clonidine—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000131	0.00406	CbGpPWpGaD
Clonidine—ADRA2A—cerebellum—germ cell cancer	0.000131	0.00336	CbGeAlD
Clonidine—Feeling abnormal—Etoposide—germ cell cancer	0.00013	0.00161	CcSEcCtD
Clonidine—Nausea—Dactinomycin—germ cell cancer	0.00013	0.0016	CcSEcCtD
Clonidine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00013	0.00402	CbGpPWpGaD
Clonidine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000129	0.00159	CcSEcCtD
Clonidine—ADRA2C—lymph node—germ cell cancer	0.000129	0.00331	CbGeAlD
Clonidine—SLC22A5—brain—germ cell cancer	0.000128	0.00328	CbGeAlD
Clonidine—Vomiting—Ifosfamide—germ cell cancer	0.000127	0.00157	CcSEcCtD
Clonidine—Hypersensitivity—Cisplatin—germ cell cancer	0.000127	0.00157	CcSEcCtD
Clonidine—Rash—Ifosfamide—germ cell cancer	0.000126	0.00156	CcSEcCtD
Clonidine—Dermatitis—Ifosfamide—germ cell cancer	0.000126	0.00155	CcSEcCtD
Clonidine—Urticaria—Etoposide—germ cell cancer	0.000126	0.00155	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—germ cell cancer	0.000125	0.00154	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—germ cell cancer	0.000125	0.00154	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—germ cell cancer	0.000125	0.00154	CcSEcCtD
Clonidine—ABCB1—decidua—germ cell cancer	0.000124	0.0032	CbGeAlD
Clonidine—Tinnitus—Methotrexate—germ cell cancer	0.000124	0.00153	CcSEcCtD
Clonidine—Asthenia—Cisplatin—germ cell cancer	0.000124	0.00153	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—germ cell cancer	0.000124	0.00153	CcSEcCtD
Clonidine—CYP2D6—female gonad—germ cell cancer	0.000124	0.00318	CbGeAlD
Clonidine—SLC22A5—lymph node—germ cell cancer	0.000123	0.00317	CbGeAlD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000122	0.00378	CbGpPWpGaD
Clonidine—Angiopathy—Methotrexate—germ cell cancer	0.000121	0.00149	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00012	0.00148	CcSEcCtD
Clonidine—Nausea—Ifosfamide—germ cell cancer	0.000119	0.00147	CcSEcCtD
Clonidine—Diarrhoea—Cisplatin—germ cell cancer	0.000118	0.00146	CcSEcCtD
Clonidine—Alopecia—Methotrexate—germ cell cancer	0.000118	0.00145	CcSEcCtD
Clonidine—CYP3A4—endocrine gland—germ cell cancer	0.000117	0.003	CbGeAlD
Clonidine—Mental disorder—Methotrexate—germ cell cancer	0.000117	0.00144	CcSEcCtD
Clonidine—Hypersensitivity—Etoposide—germ cell cancer	0.000117	0.00144	CcSEcCtD
Clonidine—Erythema—Methotrexate—germ cell cancer	0.000116	0.00143	CcSEcCtD
Clonidine—CYP2D6—endocrine gland—germ cell cancer	0.000115	0.00296	CbGeAlD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000114	0.00354	CbGpPWpGaD
Clonidine—CYP1A1—brain—germ cell cancer	0.000114	0.00293	CbGeAlD
Clonidine—SLC22A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000114	0.00353	CbGpPWpGaD
Clonidine—CYP2D6—head—germ cell cancer	0.000114	0.00292	CbGeAlD
Clonidine—Asthenia—Etoposide—germ cell cancer	0.000114	0.0014	CcSEcCtD
Clonidine—SLC22A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000112	0.00348	CbGpPWpGaD
Clonidine—Pruritus—Etoposide—germ cell cancer	0.000112	0.00138	CcSEcCtD
Clonidine—CYP1A1—lymph node—germ cell cancer	0.00011	0.00283	CbGeAlD
Clonidine—Vomiting—Cisplatin—germ cell cancer	0.00011	0.00135	CcSEcCtD
Clonidine—CYP2D6—testis—germ cell cancer	0.00011	0.00282	CbGeAlD
Clonidine—ABCB1—gonad—germ cell cancer	0.00011	0.00281	CbGeAlD
Clonidine—Vision blurred—Methotrexate—germ cell cancer	0.000109	0.00135	CcSEcCtD
Clonidine—Rash—Cisplatin—germ cell cancer	0.000109	0.00134	CcSEcCtD
Clonidine—ABCB1—uterus—germ cell cancer	0.000109	0.0028	CbGeAlD
Clonidine—Dermatitis—Cisplatin—germ cell cancer	0.000109	0.00134	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—germ cell cancer	0.000108	0.00133	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000108	0.00133	CcSEcCtD
Clonidine—ADRA1D—G alpha (q) signalling events—OXT—germ cell cancer	0.000107	0.00332	CbGpPWpGaD
Clonidine—ABCB1—pituitary gland—germ cell cancer	0.000107	0.00275	CbGeAlD
Clonidine—ADRA2A—brain—germ cell cancer	0.000106	0.00273	CbGeAlD
Clonidine—Malaise—Methotrexate—germ cell cancer	0.000105	0.00129	CcSEcCtD
Clonidine—Dizziness—Etoposide—germ cell cancer	0.000105	0.00129	CcSEcCtD
Clonidine—SLC22A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000103	0.00321	CbGpPWpGaD
Clonidine—ABCB1—medulla oblongata—germ cell cancer	0.000103	0.00265	CbGeAlD
Clonidine—ADRA2A—lymph node—germ cell cancer	0.000103	0.00264	CbGeAlD
Clonidine—Nausea—Cisplatin—germ cell cancer	0.000103	0.00126	CcSEcCtD
Clonidine—SLC6A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000102	0.00317	CbGpPWpGaD
Clonidine—CYP2D6—cerebellum—germ cell cancer	0.000101	0.0026	CbGeAlD
Clonidine—Cough—Methotrexate—germ cell cancer	0.000101	0.00125	CcSEcCtD
Clonidine—Vomiting—Etoposide—germ cell cancer	0.000101	0.00124	CcSEcCtD
Clonidine—Rash—Etoposide—germ cell cancer	9.98e-05	0.00123	CcSEcCtD
Clonidine—Dermatitis—Etoposide—germ cell cancer	9.97e-05	0.00123	CcSEcCtD
Clonidine—Headache—Etoposide—germ cell cancer	9.92e-05	0.00122	CcSEcCtD
Clonidine—Chest pain—Methotrexate—germ cell cancer	9.89e-05	0.00122	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—germ cell cancer	9.89e-05	0.00122	CcSEcCtD
Clonidine—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.89e-05	0.00306	CbGpPWpGaD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	9.82e-05	0.00121	CcSEcCtD
Clonidine—Discomfort—Methotrexate—germ cell cancer	9.77e-05	0.0012	CcSEcCtD
Clonidine—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.74e-05	0.00302	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	9.59e-05	0.00297	CbGpPWpGaD
Clonidine—Confusional state—Methotrexate—germ cell cancer	9.56e-05	0.00118	CcSEcCtD
Clonidine—ABCB1—adrenal gland—germ cell cancer	9.55e-05	0.00245	CbGeAlD
Clonidine—ABCB1—midbrain—germ cell cancer	9.43e-05	0.00242	CbGeAlD
Clonidine—Infection—Methotrexate—germ cell cancer	9.42e-05	0.00116	CcSEcCtD
Clonidine—Nausea—Etoposide—germ cell cancer	9.4e-05	0.00116	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—germ cell cancer	9.3e-05	0.00115	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—germ cell cancer	9.28e-05	0.00114	CcSEcCtD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—CD9—germ cell cancer	9.27e-05	0.00287	CbGpPWpGaD
Clonidine—ABCB1—bone marrow—germ cell cancer	9.24e-05	0.00237	CbGeAlD
Clonidine—Skin disorder—Methotrexate—germ cell cancer	9.21e-05	0.00113	CcSEcCtD
Clonidine—ABCB1—spinal cord—germ cell cancer	9.2e-05	0.00236	CbGeAlD
Clonidine—Hyperhidrosis—Methotrexate—germ cell cancer	9.17e-05	0.00113	CcSEcCtD
Clonidine—Anorexia—Methotrexate—germ cell cancer	9.04e-05	0.00111	CcSEcCtD
Clonidine—ABCB1—female gonad—germ cell cancer	8.91e-05	0.00229	CbGeAlD
Clonidine—ADRA1B—G alpha (q) signalling events—OXT—germ cell cancer	8.9e-05	0.00276	CbGpPWpGaD
Clonidine—Hypotension—Methotrexate—germ cell cancer	8.86e-05	0.00109	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	8.64e-05	0.00106	CcSEcCtD
Clonidine—SLC22A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	8.6e-05	0.00266	CbGpPWpGaD
Clonidine—Insomnia—Methotrexate—germ cell cancer	8.58e-05	0.00106	CcSEcCtD
Clonidine—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	8.57e-05	0.00265	CbGpPWpGaD
Clonidine—Paraesthesia—Methotrexate—germ cell cancer	8.51e-05	0.00105	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—germ cell cancer	8.45e-05	0.00104	CcSEcCtD
Clonidine—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	8.44e-05	0.00261	CbGpPWpGaD
Clonidine—Somnolence—Methotrexate—germ cell cancer	8.43e-05	0.00104	CcSEcCtD
Clonidine—ABCB1—endocrine gland—germ cell cancer	8.28e-05	0.00213	CbGeAlD
Clonidine—Decreased appetite—Methotrexate—germ cell cancer	8.24e-05	0.00102	CcSEcCtD
Clonidine—CYP2D6—brain—germ cell cancer	8.24e-05	0.00212	CbGeAlD
Clonidine—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.19e-05	0.00101	CcSEcCtD
Clonidine—ABCB1—head—germ cell cancer	8.18e-05	0.0021	CbGeAlD
Clonidine—Fatigue—Methotrexate—germ cell cancer	8.18e-05	0.00101	CcSEcCtD
Clonidine—Pain—Methotrexate—germ cell cancer	8.11e-05	0.000999	CcSEcCtD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	7.96e-05	0.00247	CbGpPWpGaD
Clonidine—ADRA1A—G alpha (q) signalling events—OXT—germ cell cancer	7.9e-05	0.00245	CbGpPWpGaD
Clonidine—ABCB1—testis—germ cell cancer	7.9e-05	0.00203	CbGeAlD
Clonidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	7.82e-05	0.00242	CbGpPWpGaD
Clonidine—Feeling abnormal—Methotrexate—germ cell cancer	7.81e-05	0.000962	CcSEcCtD
Clonidine—SLC22A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.8e-05	0.00242	CbGpPWpGaD
Clonidine—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	7.78e-05	0.00241	CbGpPWpGaD
Clonidine—Gastrointestinal pain—Methotrexate—germ cell cancer	7.75e-05	0.000955	CcSEcCtD
Clonidine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.68e-05	0.00238	CbGpPWpGaD
Clonidine—Urticaria—Methotrexate—germ cell cancer	7.53e-05	0.000928	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—germ cell cancer	7.5e-05	0.000923	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—germ cell cancer	7.5e-05	0.000923	CcSEcCtD
Clonidine—ADRA1D—G alpha (q) signalling events—AVP—germ cell cancer	7.35e-05	0.00228	CbGpPWpGaD
Clonidine—ABCB1—cerebellum—germ cell cancer	7.3e-05	0.00187	CbGeAlD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	7.1e-05	0.0022	CbGpPWpGaD
Clonidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.09e-05	0.0022	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	7.07e-05	0.00219	CbGpPWpGaD
Clonidine—Hypersensitivity—Methotrexate—germ cell cancer	6.99e-05	0.00086	CcSEcCtD
Clonidine—Asthenia—Methotrexate—germ cell cancer	6.8e-05	0.000838	CcSEcCtD
Clonidine—Pruritus—Methotrexate—germ cell cancer	6.71e-05	0.000826	CcSEcCtD
Clonidine—SLC6A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.69e-05	0.00207	CbGpPWpGaD
Clonidine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.59e-05	0.00204	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	6.57e-05	0.00204	CbGpPWpGaD
Clonidine—Diarrhoea—Methotrexate—germ cell cancer	6.49e-05	0.000799	CcSEcCtD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	6.41e-05	0.00199	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—CD9—germ cell cancer	6.3e-05	0.00195	CbGpPWpGaD
Clonidine—Dizziness—Methotrexate—germ cell cancer	6.27e-05	0.000772	CcSEcCtD
Clonidine—ADRA1B—G alpha (q) signalling events—AVP—germ cell cancer	6.1e-05	0.00189	CbGpPWpGaD
Clonidine—SLC6A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.07e-05	0.00188	CbGpPWpGaD
Clonidine—Vomiting—Methotrexate—germ cell cancer	6.03e-05	0.000742	CcSEcCtD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.99e-05	0.00185	CbGpPWpGaD
Clonidine—Rash—Methotrexate—germ cell cancer	5.98e-05	0.000736	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—germ cell cancer	5.97e-05	0.000736	CcSEcCtD
Clonidine—Headache—Methotrexate—germ cell cancer	5.94e-05	0.000732	CcSEcCtD
Clonidine—ABCB1—brain—germ cell cancer	5.93e-05	0.00152	CbGeAlD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.89e-05	0.00183	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—CD9—germ cell cancer	5.88e-05	0.00182	CbGpPWpGaD
Clonidine—ABCB1—lymph node—germ cell cancer	5.73e-05	0.00147	CbGeAlD
Clonidine—Nausea—Methotrexate—germ cell cancer	5.63e-05	0.000694	CcSEcCtD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	5.45e-05	0.00169	CbGpPWpGaD
Clonidine—ADRA1A—G alpha (q) signalling events—AVP—germ cell cancer	5.42e-05	0.00168	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—OXT—germ cell cancer	5.41e-05	0.00167	CbGpPWpGaD
Clonidine—SLC22A4—Transmembrane transport of small molecules—AVP—germ cell cancer	5.26e-05	0.00163	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.23e-05	0.00162	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	5.14e-05	0.00159	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.03e-05	0.00156	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.95e-05	0.00153	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—OXT—germ cell cancer	4.88e-05	0.00151	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.87e-05	0.00151	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	4.86e-05	0.00151	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	4.84e-05	0.0015	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—CD9—germ cell cancer	4.78e-05	0.00148	CbGpPWpGaD
Clonidine—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.56e-05	0.00141	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—OXT—germ cell cancer	4.56e-05	0.00141	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.5e-05	0.0014	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—OXT—germ cell cancer	4.49e-05	0.00139	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.39e-05	0.00136	CbGpPWpGaD
Clonidine—ADRA1B—LPA receptor mediated events—HRAS—germ cell cancer	4.34e-05	0.00134	CbGpPWpGaD
Clonidine—ADRA1B—AMPK Signaling—TP53—germ cell cancer	4.27e-05	0.00132	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.1e-05	0.00127	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.04e-05	0.00125	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	4.04e-05	0.00125	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—SLC2A3—germ cell cancer	4.03e-05	0.00125	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—OXT—germ cell cancer	3.99e-05	0.00123	CbGpPWpGaD
Clonidine—SLC22A3—Transmembrane transport of small molecules—AVP—germ cell cancer	3.97e-05	0.00123	CbGpPWpGaD
Clonidine—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	3.95e-05	0.00122	CbGpPWpGaD
Clonidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.9e-05	0.00121	CbGpPWpGaD
Clonidine—ADRA1A—AMPK Signaling—TP53—germ cell cancer	3.79e-05	0.00118	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—AVP—germ cell cancer	3.71e-05	0.00115	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—OXT—germ cell cancer	3.7e-05	0.00115	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.59e-05	0.00111	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—AVP—germ cell cancer	3.35e-05	0.00104	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.33e-05	0.00103	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.28e-05	0.00102	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CRABP1—germ cell cancer	3.23e-05	0.001	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—AVP—germ cell cancer	3.13e-05	0.000968	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.11e-05	0.000965	CbGpPWpGaD
Clonidine—SLC6A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.09e-05	0.000956	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—AVP—germ cell cancer	3.08e-05	0.000953	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—OXT—germ cell cancer	3.06e-05	0.000946	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.95e-05	0.000913	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.9e-05	0.000899	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—OXT—germ cell cancer	2.77e-05	0.00086	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—OXT—germ cell cancer	2.76e-05	0.000855	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—AVP—germ cell cancer	2.73e-05	0.000846	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—OXT—germ cell cancer	2.58e-05	0.000798	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	2.57e-05	0.000797	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—AVP—germ cell cancer	2.54e-05	0.000786	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—OXT—germ cell cancer	2.54e-05	0.000786	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—OXT—germ cell cancer	2.5e-05	0.000776	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—SLC2A3—germ cell cancer	2.46e-05	0.000761	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—SLC22A3—germ cell cancer	2.42e-05	0.00075	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—SLC2A3—germ cell cancer	2.35e-05	0.000729	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—OXT—germ cell cancer	2.34e-05	0.000725	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—SLC22A3—germ cell cancer	2.32e-05	0.000718	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.32e-05	0.000718	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—OXT—germ cell cancer	2.3e-05	0.000713	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—OXT—germ cell cancer	2.25e-05	0.000698	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AVP—germ cell cancer	2.09e-05	0.000649	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—OXT—germ cell cancer	2.09e-05	0.000648	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—OXT—germ cell cancer	2.05e-05	0.000634	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—SLC2A3—germ cell cancer	2e-05	0.000618	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.99e-05	0.000615	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.98e-05	0.000614	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CRABP1—germ cell cancer	1.97e-05	0.000611	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—SLC22A3—germ cell cancer	1.97e-05	0.000609	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AVP—germ cell cancer	1.9e-05	0.000589	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—OXT—germ cell cancer	1.9e-05	0.000589	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AVP—germ cell cancer	1.89e-05	0.000586	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CRABP1—germ cell cancer	1.89e-05	0.000586	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.83e-05	0.000566	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.8e-05	0.000558	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AVP—germ cell cancer	1.77e-05	0.000547	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AVP—germ cell cancer	1.74e-05	0.000538	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—SLC2A3—germ cell cancer	1.73e-05	0.000535	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AVP—germ cell cancer	1.72e-05	0.000532	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—SLC22A3—germ cell cancer	1.7e-05	0.000527	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.7e-05	0.000526	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.65e-05	0.00051	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—OXT—germ cell cancer	1.64e-05	0.000508	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AVP—germ cell cancer	1.6e-05	0.000497	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CRABP1—germ cell cancer	1.6e-05	0.000496	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AVP—germ cell cancer	1.58e-05	0.000489	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AVP—germ cell cancer	1.54e-05	0.000478	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—OXT—germ cell cancer	1.48e-05	0.000458	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CRABP1—germ cell cancer	1.47e-05	0.000455	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.46e-05	0.000453	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AVP—germ cell cancer	1.43e-05	0.000444	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AVP—germ cell cancer	1.4e-05	0.000434	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—FGF4—germ cell cancer	1.4e-05	0.000433	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CRABP1—germ cell cancer	1.39e-05	0.00043	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—OXT—germ cell cancer	1.38e-05	0.000428	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.38e-05	0.000427	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—OXT—germ cell cancer	1.36e-05	0.000421	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.36e-05	0.000421	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.36e-05	0.000421	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.31e-05	0.000407	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	1.3e-05	0.000404	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—HRAS—germ cell cancer	1.3e-05	0.000403	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.3e-05	0.000403	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.28e-05	0.000397	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGF4—germ cell cancer	1.26e-05	0.000391	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—H2AFZ—germ cell cancer	1.25e-05	0.000387	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—OXT—germ cell cancer	1.21e-05	0.000374	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGF4—germ cell cancer	1.18e-05	0.000365	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGF4—germ cell cancer	1.16e-05	0.00036	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KITLG—germ cell cancer	1.15e-05	0.000356	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—H2AFZ—germ cell cancer	1.13e-05	0.000349	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AVP—germ cell cancer	1.12e-05	0.000348	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—OXT—germ cell cancer	1.12e-05	0.000348	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CRABP1—germ cell cancer	1.11e-05	0.000343	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.1e-05	0.000341	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.09e-05	0.000336	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.08e-05	0.000334	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—H2AFZ—germ cell cancer	1.05e-05	0.000326	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.04e-05	0.000323	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KITLG—germ cell cancer	1.04e-05	0.000321	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	0.000321	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGF4—germ cell cancer	1.03e-05	0.00032	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AVP—germ cell cancer	1.01e-05	0.000314	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KITLG—germ cell cancer	9.69e-06	0.0003	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	9.58e-06	0.000297	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KITLG—germ cell cancer	9.54e-06	0.000296	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AVP—germ cell cancer	9.47e-06	0.000293	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—germ cell cancer	9.44e-06	0.000292	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AVP—germ cell cancer	9.32e-06	0.000289	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—H2AFZ—germ cell cancer	9.21e-06	0.000285	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—HRAS—germ cell cancer	9.03e-06	0.00028	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CRABP1—germ cell cancer	8.84e-06	0.000274	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—germ cell cancer	8.82e-06	0.000273	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	8.56e-06	0.000265	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—FGFR3—germ cell cancer	8.54e-06	0.000265	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	8.5e-06	0.000263	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KITLG—germ cell cancer	8.47e-06	0.000262	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—HRAS—germ cell cancer	8.43e-06	0.000261	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	8.37e-06	0.000259	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AVP—germ cell cancer	8.28e-06	0.000257	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	7.87e-06	0.000244	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KIT—germ cell cancer	7.84e-06	0.000243	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGFR3—germ cell cancer	7.71e-06	0.000239	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AVP—germ cell cancer	7.69e-06	0.000238	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGFR3—germ cell cancer	7.2e-06	0.000223	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—germ cell cancer	7.16e-06	0.000222	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGFR3—germ cell cancer	7.09e-06	0.00022	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KIT—germ cell cancer	7.08e-06	0.000219	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—HRAS—germ cell cancer	6.85e-06	0.000212	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CRABP1—germ cell cancer	6.83e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KIT—germ cell cancer	6.61e-06	0.000205	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KIT—germ cell cancer	6.51e-06	0.000202	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGFR3—germ cell cancer	6.3e-06	0.000195	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	5.85e-06	0.000181	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KIT—germ cell cancer	5.78e-06	0.000179	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—germ cell cancer	5.74e-06	0.000178	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KIT—germ cell cancer	5.37e-06	0.000166	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—germ cell cancer	5.18e-06	0.00016	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—germ cell cancer	4.84e-06	0.00015	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—germ cell cancer	4.76e-06	0.000148	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—germ cell cancer	4.32e-06	0.000134	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—germ cell cancer	4.23e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	3.93e-06	0.000122	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—germ cell cancer	3.9e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—germ cell cancer	3.64e-06	0.000113	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—germ cell cancer	3.58e-06	0.000111	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—germ cell cancer	3.54e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—germ cell cancer	3.39e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—germ cell cancer	3.2e-06	9.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—germ cell cancer	3.18e-06	9.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—germ cell cancer	3.06e-06	9.48e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—germ cell cancer	2.99e-06	9.26e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—germ cell cancer	2.96e-06	9.16e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—germ cell cancer	2.94e-06	9.11e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—germ cell cancer	2.86e-06	8.85e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—germ cell cancer	2.81e-06	8.71e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—germ cell cancer	2.61e-06	8.09e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—germ cell cancer	2.5e-06	7.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—germ cell cancer	2.43e-06	7.52e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	2.32e-06	7.19e-05	CbGpPWpGaD
